Form D — Clover Biopharmaceuticals, Ltd.
0001856491-25-000001 · filed Apr 28, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $904,859
- Reported amount sold
- $904,859
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Clover Biopharmaceuticals, Ltd.
- CIK
- 1856491
- Entity
- Corporation
- Jurisdiction
- CAYMAN ISLANDS
- Year incorporated
- —
- Address
- B5-19,BUILDING,HIGH-TECH INCUBATION PARK
CHENGDU, F4 610041 - Phone
- 0086-28-8533-6966
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Peng Liang · Executive OfficerChengdu, F4 Find on LinkedIn ↗
-
Joshua Liang · Executive OfficerChengdu, F4 Find on LinkedIn ↗
-
Xiaodong Wang · DirectorYarrow Point, WA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗